Abstract
A continuous supply of oxygen to tissues is vital to life and interruptions in its delivery are poorly tolerated. The treatment of low-blood oxygen tensions requires restoration of functional airways and lungs. Unfortunately, severe oxygen deprivation carries a high mortality rate and can make otherwise-survivable illnesses unsurvivable. Thus, an effective and rapid treatment for hypoxemia would be revolutionary. The i.v. injection of oxygen bubbles has recently emerged as a potential strategy to rapidly raise arterial oxygen tensions. In this report, we describe the fabrication of a polymerbased intravascular oxygen delivery agent. Polymer hollowmicroparticles (PHMs) are thin-walled, hollow polymer microcapsules with tunable nanoporous shells. We show that PHMs are easily charged with oxygen gas and that they release their oxygen payload only when exposed to desaturated blood. We demonstrate that oxygen release from PHMs is diffusion-controlled, that they deliver approximately five times more oxygen gas than human red blood cells (per gram), and that they are safe and effective when injected in vivo. Finally, we show that PHMs can be stored at room temperature under dry ambient conditions for at least 2 mo without any effect on particle size distribution or gas carrying capacity.
Author supplied keywords
Cite
CITATION STYLE
Seekell, R. P., Lock, A. T., Peng, Y., Cole, A. R., Perry, D. A., Kheir, J. N., & Polizzotti, B. D. (2016). Oxygen delivery using engineered microparticles. Proceedings of the National Academy of Sciences of the United States of America, 113(44), 12380–12385. https://doi.org/10.1073/pnas.1608438113
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.